메뉴 건너뛰기




Volumn 107, Issue 47, 2010, Pages 20565-20570

CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells

Author keywords

Chemotaxis; CXCR4 antagonist; HIV; Nanobody; Stem cell mobilization

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CHEMOKINE RECEPTOR CXCR4 NANOBODY; EPITOPE; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

EID: 78650573881     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1012865107     Document Type: Article
Times cited : (218)

References (50)
  • 2
    • 47049106660 scopus 로고    scopus 로고
    • Antibodies against G-protein coupled receptors: Novel uses in screening and drug development
    • Gupta A, Heimann AS, Gomes I, Devi LA (2008) Antibodies against G-protein coupled receptors: Novel uses in screening and drug development. Comb Chem High Throughput Screen 11:463-467.
    • (2008) Comb Chem High Throughput Screen , vol.11 , pp. 463-467
    • Gupta, A.1    Heimann, A.S.2    Gomes, I.3    Devi, L.A.4
  • 3
    • 35348819390 scopus 로고    scopus 로고
    • Properties, production, and applications of camelid single-domain antibody fragments
    • Harmsen MM, De Haard HJ (2007) Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol 77:13-22.
    • (2007) Appl Microbiol Biotechnol , vol.77 , pp. 13-22
    • Harmsen, M.M.1    De Haard, H.J.2
  • 4
    • 33645241975 scopus 로고    scopus 로고
    • Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
    • De Genst E, et al. (2006) Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc Natl Acad Sci USA 103:4586-4591.
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 4586-4591
    • De Genst, E.1
  • 5
    • 35748949254 scopus 로고    scopus 로고
    • Structure of an IgNAR-AMA 1 complex: Targeting a conserved hydrophobic cleft broadens malarial strain recognition
    • Henderson KA, et al. (2007) Structure of an IgNAR-AMA1 complex: Targeting a conserved hydrophobic cleft broadens malarial strain recognition. Structure 15: 1452-1466.
    • (2007) Structure , vol.15 , pp. 1452-1466
    • Henderson, K.A.1
  • 6
    • 0344447084 scopus 로고    scopus 로고
    • Potent enzyme inhibitors derived from dromedary heavychain antibodies
    • Lauwereys M, et al. (1998) Potent enzyme inhibitors derived from dromedary heavychain antibodies. EMBO J 17:3512-3520.
    • (1998) EMBO J , vol.17 , pp. 3512-3520
    • Lauwereys, M.1
  • 7
    • 9144220168 scopus 로고    scopus 로고
    • Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm
    • Stijlemans B, et al. (2004) Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J Biol Chem 279:1256-1261.
    • (2004) J Biol Chem , vol.279 , pp. 1256-1261
    • Stijlemans, B.1
  • 9
    • 0034235930 scopus 로고    scopus 로고
    • Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease
    • Gonzalo JA, et al. (2000) Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J Immunol 165:499-508.
    • (2000) J Immunol , vol.165 , pp. 499-508
    • Gonzalo, J.A.1
  • 10
    • 0035887637 scopus 로고    scopus 로고
    • AMD3100, a potent and specific antagonist of the stromal cellderived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice
    • Matthys P, et al. (2001) AMD3100, a potent and specific antagonist of the stromal cellderived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. J Immunol 167:4686-4692.
    • (2001) J Immunol , vol.167 , pp. 4686-4692
    • Matthys, P.1
  • 11
    • 33750294009 scopus 로고    scopus 로고
    • The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis
    • Ratajczak MZ, et al. (2006) The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 20:1915-1924.
    • (2006) Leukemia , vol.20 , pp. 1915-1924
    • Ratajczak, M.Z.1
  • 12
    • 33344464945 scopus 로고    scopus 로고
    • CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment
    • Burger JA, Kipps TJ (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761-1767.
    • (2006) Blood , vol.107 , pp. 1761-1767
    • Burger, J.A.1    Kipps, T.J.2
  • 13
    • 0030002637 scopus 로고    scopus 로고
    • HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
    • Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272: 872-877. (Pubitemid 26154590)
    • (1996) Science , vol.272 , Issue.5263 , pp. 872-877
    • Feng, Y.1    Broder, C.C.2    Kennedy, P.E.3    Berger, E.A.4
  • 14
    • 47949103559 scopus 로고    scopus 로고
    • CXCR4, inhibitors and mechanisms of action
    • Liang X (2008) CXCR4, inhibitors and mechanisms of action. Chem Biol Drug Des 72: 97-110.
    • (2008) Chem Biol Drug des , vol.72 , pp. 97-110
    • Liang, X.1
  • 15
    • 4644227515 scopus 로고    scopus 로고
    • Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection
    • AMD3100 HIV Study Group
    • Hendrix CW, et al.; AMD3100 HIV Study Group (2004) Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr 37:1253-1262.
    • (2004) J Acquir Immune Defic Syndr , vol.37 , pp. 1253-1262
    • Hendrix, C.W.1
  • 16
    • 71249160513 scopus 로고    scopus 로고
    • Plerixafor hydrochloride: A novel agent for the mobilization of peripheral blood stem cells
    • Cashen AF (2009) Plerixafor hydrochloride: A novel agent for the mobilization of peripheral blood stem cells. Drugs Today (Barc) 45:497-505.
    • (2009) Drugs Today (Barc) , vol.45 , pp. 497-505
    • Cashen, A.F.1
  • 17
    • 70350450580 scopus 로고    scopus 로고
    • Phase III prospective randomized doubleblind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma
    • 3101 Investigators
    • DiPersio JF, et al.; 3101 Investigators (2009) Phase III prospective randomized doubleblind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. J Clin Oncol 27:4767-4773.
    • (2009) J Clin Oncol , vol.27 , pp. 4767-4773
    • Dipersio, J.F.1
  • 18
    • 67651089936 scopus 로고    scopus 로고
    • Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
    • 3102 Investigators
    • DiPersio JF, et al.; 3102 Investigators (2009) Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood 113:5720-5726.
    • (2009) Blood , vol.113 , pp. 5720-5726
    • Dipersio, J.F.1
  • 19
    • 0031024664 scopus 로고    scopus 로고
    • Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent
    • McKnight A, et al. (1997) Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J Virol 71:1692-1696.
    • (1997) J Virol , vol.71 , pp. 1692-1696
    • McKnight, A.1
  • 20
    • 0035282432 scopus 로고    scopus 로고
    • Involvement of chemokine receptors in breast cancer metastasis
    • Müller A, et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56.
    • (2001) Nature , vol.410 , pp. 50-56
    • Müller, A.1
  • 21
    • 16344394606 scopus 로고    scopus 로고
    • Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells
    • Ottaiano A, et al. (2005) Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells. Cancer Immunol Immunother 54:781-791.
    • (2005) Cancer Immunol Immunother , vol.54 , pp. 781-791
    • Ottaiano, A.1
  • 22
    • 0030946088 scopus 로고    scopus 로고
    • A monoclonal antibody (12G5) directed against CXCR-4 inhibits infection with the dual-tropic human immunodeficiency virus type 1 isolate HIV-1(89.6) but not the T-tropic isolate HIV-1(HxB)
    • Strizki JM, Turner JD, Collman RG, Hoxie J, González-Scarano F (1997) A monoclonal antibody (12G5) directed against CXCR-4 inhibits infection with the dual-tropic human immunodeficiency virus type 1 isolate HIV-1(89.6) but not the T-tropic isolate HIV-1(HxB). J Virol 71:5678-5683.
    • (1997) J Virol , vol.71 , pp. 5678-5683
    • Strizki, J.M.1    Turner, J.D.2    Collman, R.G.3    Hoxie, J.4    González-Scarano, F.5
  • 23
    • 4143072487 scopus 로고    scopus 로고
    • CXCR4 and CXCL12 (SDF-1) in prostate cancer: Inhibitory effects of human single chain Fv antibodies
    • Vaday GG, et al. (2004) CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies. Clin Cancer Res 10:5630-5639.
    • (2004) Clin Cancer Res , vol.10 , pp. 5630-5639
    • Vaday, G.G.1
  • 24
    • 34848879175 scopus 로고    scopus 로고
    • Human anti-CXCR4 antibodies undergo VH replacement, exhibit functional V-region sulfation, and define CXCR4 antigenic heterogeneity
    • Xu C, Sui J, Tao H, Zhu Q, Marasco WA (2007) Human anti-CXCR4 antibodies undergo VH replacement, exhibit functional V-region sulfation, and define CXCR4 antigenic heterogeneity. J Immunol 179:2408-2418.
    • (2007) J Immunol , vol.179 , pp. 2408-2418
    • Xu, C.1    Sui, J.2    Tao, H.3    Zhu, Q.4    Marasco, W.A.5
  • 25
    • 0034858033 scopus 로고    scopus 로고
    • Antigenically distinct conformations of CXCR4
    • Baribaud F, et al. (2001) Antigenically distinct conformations of CXCR4. J Virol 75: 8957-8967.
    • (2001) J Virol , vol.75 , pp. 8957-8967
    • Baribaud, F.1
  • 26
    • 13744249282 scopus 로고    scopus 로고
    • Anti-CXCR4 monoclonal antibodies recognizing overlapping epitopes differ significantly in their ability to inhibit entry of human immunodeficiency virus type 1
    • Carnec X, Quan L, Olson WC, Hazan U, Dragic T (2005) Anti-CXCR4 monoclonal antibodies recognizing overlapping epitopes differ significantly in their ability to inhibit entry of human immunodeficiency virus type 1. J Virol 79:1930-1933.
    • (2005) J Virol , vol.79 , pp. 1930-1933
    • Carnec, X.1    Quan, L.2    Olson, W.C.3    Hazan, U.4    Dragic, T.5
  • 27
    • 0033151694 scopus 로고    scopus 로고
    • Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors
    • Coward P, Chan SD, Wada HG, Humphries GM, Conklin BR (1999) Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors. Anal Biochem 270: 242-248.
    • (1999) Anal Biochem , vol.270 , pp. 242-248
    • Coward, P.1    Chan, S.D.2    Wada, H.G.3    Humphries, G.M.4    Conklin, B.R.5
  • 28
    • 67650349084 scopus 로고    scopus 로고
    • CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
    • Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B (2009) CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113:6085-6093.
    • (2009) Blood , vol.113 , pp. 6085-6093
    • Levoye, A.1    Balabanian, K.2    Baleux, F.3    Bachelerie, F.4    Lagane, B.5
  • 29
    • 0034604709 scopus 로고    scopus 로고
    • Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities
    • Brelot A, Heveker N, Montes M, Alizon M (2000) Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities. J Biol Chem 275:23736-23744.
    • (2000) J Biol Chem , vol.275 , pp. 23736-23744
    • Brelot, A.1    Heveker, N.2    Montes, M.3    Alizon, M.4
  • 30
    • 71749113474 scopus 로고    scopus 로고
    • Structural basis of the interaction between chemokine stromal cell-derived factor-1/CXCL12 and its G-protein-coupled receptor CXCR4
    • Kofuku Y, et al. (2009) Structural basis of the interaction between chemokine stromal cell-derived factor-1/CXCL12 and its G-protein-coupled receptor CXCR4. J Biol Chem 284:35240-35250.
    • (2009) J Biol Chem , vol.284 , pp. 35240-35250
    • Kofuku, Y.1
  • 31
    • 0035900771 scopus 로고    scopus 로고
    • Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies
    • Zhou N, et al. (2001) Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies. J Biol Chem 276:42826-42833.
    • (2001) J Biol Chem , vol.276 , pp. 42826-42833
    • Zhou, N.1
  • 32
    • 70349094934 scopus 로고    scopus 로고
    • Atomic-level mapping of antibody epitopes on a GPCR
    • Paes C, et al. (2009) Atomic-level mapping of antibody epitopes on a GPCR. J Am Chem Soc 131:6952-6954.
    • (2009) J Am Chem Soc , vol.131 , pp. 6952-6954
    • Paes, C.1
  • 33
    • 33745032737 scopus 로고    scopus 로고
    • Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis
    • Coppieters K, et al. (2006) Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis. Arthritis Rheum 54:1856-1866.
    • (2006) Arthritis Rheum , vol.54 , pp. 1856-1866
    • Coppieters, K.1
  • 34
    • 33845922737 scopus 로고    scopus 로고
    • Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR nanobodies
    • Roovers RC, et al. (2007) Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR nanobodies. Cancer Immunol Immunother 56:303-317.
    • (2007) Cancer Immunol Immunother , vol.56 , pp. 303-317
    • Roovers, R.C.1
  • 35
    • 0344255688 scopus 로고    scopus 로고
    • Pentamerization of single-domain antibodies from phage libraries: A novel strategy for the rapid generation of high-avidity antibody reagents
    • Zhang J, et al. (2004) Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents. J Mol Biol 335:49-56.
    • (2004) J Mol Biol , vol.335 , pp. 49-56
    • Zhang, J.1
  • 36
    • 0037025357 scopus 로고    scopus 로고
    • A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists
    • Zhang WB, et al. (2002) A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists. J Biol Chem 277:24515-24521.
    • (2002) J Biol Chem , vol.277 , pp. 24515-24521
    • Zhang, W.B.1
  • 37
    • 57349105727 scopus 로고    scopus 로고
    • Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors
    • Wong RS, et al. (2008) Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors. Mol Pharmacol 74:1485-1495.
    • (2008) Mol Pharmacol , vol.74 , pp. 1485-1495
    • Wong, R.S.1
  • 38
    • 44649101927 scopus 로고    scopus 로고
    • G protein-coupled receptor dimers: Functional consequences, disease states and drug targets
    • Dalrymple MB, Pfleger KD, Eidne KA (2008) G protein-coupled receptor dimers: functional consequences, disease states and drug targets. Pharmacol Ther 118:359-371.
    • (2008) Pharmacol Ther , vol.118 , pp. 359-371
    • Dalrymple, M.B.1    Pfleger, K.D.2    Eidne, K.A.3
  • 39
    • 23944501304 scopus 로고    scopus 로고
    • Heterodimerization of g protein-coupled receptors: Specificity and functional significance
    • Prinster SC, Hague C, Hall RA (2005) Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol Rev 57:289-298.
    • (2005) Pharmacol Rev , vol.57 , pp. 289-298
    • Prinster, S.C.1    Hague, C.2    Hall, R.A.3
  • 40
    • 0037474238 scopus 로고    scopus 로고
    • Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor
    • Babcock GJ, Farzan M, Sodroski J (2003) Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J Biol Chem 278:3378-3385.
    • (2003) J Biol Chem , vol.278 , pp. 3378-3385
    • Babcock, G.J.1    Farzan, M.2    Sodroski, J.3
  • 41
    • 47249114905 scopus 로고    scopus 로고
    • CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome
    • Lagane B, et al. (2008) CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. Blood 112: 34-44.
    • (2008) Blood , vol.112 , pp. 34-44
    • Lagane, B.1
  • 42
    • 33750447940 scopus 로고    scopus 로고
    • Dimerization of CXCR4 in living malignant cells: Control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions
    • Wang J, He L, Combs CA, Roderiquez G, Norcross MA (2006) Dimerization of CXCR4 in living malignant cells: Control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions. Mol Cancer Ther 5:2474-2483.
    • (2006) Mol Cancer Ther , vol.5 , pp. 2474-2483
    • Wang, J.1    He, L.2    Combs, C.A.3    Roderiquez, G.4    Norcross, M.A.5
  • 43
    • 0347627709 scopus 로고    scopus 로고
    • Constitutive activity and inverse agonists of G protein-coupled receptors: A current perspective
    • Milligan G (2003) Constitutive activity and inverse agonists of G protein-coupled receptors: A current perspective. Mol Pharmacol 64:1271-1276.
    • (2003) Mol Pharmacol , vol.64 , pp. 1271-1276
    • Milligan, G.1
  • 44
    • 0035083109 scopus 로고    scopus 로고
    • Inverse, protean, and ligand-selective agonism: Matters of receptor conformation
    • Kenakin T (2001) Inverse, protean, and ligand-selective agonism: Matters of receptor conformation. FASEB J 15:598-611.
    • (2001) FASEB J , vol.15 , pp. 598-611
    • Kenakin, T.1
  • 45
    • 64549094665 scopus 로고    scopus 로고
    • Interaction between CXCR4 and CCL20 pathways regulates tumor growth
    • Beider K, et al. (2009) Interaction between CXCR4 and CCL20 pathways regulates tumor growth. PLoS ONE 4:e5125.
    • (2009) PLoS ONE , vol.4
    • Beider, K.1
  • 46
    • 64249173226 scopus 로고    scopus 로고
    • The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
    • De Clercq E (2009) The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil). Biochem Pharmacol 77:1655-1664.
    • (2009) Biochem Pharmacol , vol.77 , pp. 1655-1664
    • De Clercq, E.1
  • 47
    • 23944525352 scopus 로고    scopus 로고
    • The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone
    • Flomenberg N, et al. (2005) The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 106: 1867-1874.
    • (2005) Blood , vol.106 , pp. 1867-1874
    • Flomenberg, N.1
  • 48
    • 0032868653 scopus 로고    scopus 로고
    • Therapeutic antibody fragments with prolonged in vivo half-lives
    • Chapman AP, et al. (1999) Therapeutic antibody fragments with prolonged in vivo half-lives. Nat Biotechnol 17:780-783.
    • (1999) Nat Biotechnol , vol.17 , pp. 780-783
    • Chapman, A.P.1
  • 50
    • 33846820458 scopus 로고    scopus 로고
    • Passive immunization of guinea pigs with llama singledomain antibody fragments against foot-and-mouth disease
    • Harmsen MM, et al. (2007) Passive immunization of guinea pigs with llama singledomain antibody fragments against foot-and-mouth disease. Vet Microbiol 120: 193-206.
    • (2007) Vet Microbiol , vol.120 , pp. 193-206
    • Harmsen, M.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.